Captopril, a potent angiotensin-converting enzyme (ACE) inhibitor, has shown to be a valuable therapeutic agent in the management of hypertension and other cardiovascular diseases. Its pharmacological involves blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This causes vasodilation and a decrease in blood press